M Kraft1, C Lewis, D Pham, H W Chu. 1. Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, 1400 Jackson St., Denver, CO 80206, USA.
Abstract
BACKGROUND: IL-4 and IL-13 have been shown to be critical for expression of the asthma phenotype in a murine model and may modulate human fibroblast function. OBJECTIVE: We hypothesized that IL-4 and IL-13 would increase airway fibroblast proliferation and reduce the ability of dexamethasone to decrease this proliferation. METHODS: Six subjects with severe asthma, 5 subjects with mild asthma, and 5 healthy subjects underwent bronchoscopy with endobronchial biopsy. Biopsy specimens were placed in Dulbecco modified Eagle medium and cultured, and only fibro-blasts from the first and second passages were evaluated. Cells were incubated with IL-4 (50 ng/mL), IL-13 (10 ng/mL), and the combination for 48 hours in the presence and absence of dexamethasone, 10(-7) mol/L, and 10(-8) mol/L. Fibroblasts were also incubated with IFN-gamma at 50 ng/mL to assess the response of a T(H)1 cytokine on proliferation. RESULTS: Fibroblast proliferation, determined by (3)H-thymidine incorporation, was significantly increased by IL-4 in subjects with mild asthma as compared with IL-4 in subjects with severe asthma and healthy subjects (P =.003), IL-13 (P =.011), and the combination (P =.004). Dexamethasone also increased proliferation in the group with mild asthma as compared with the group with severe asthma and the healthy group (10(-7) mol/L, P =.02; 10(-8) mol/L, P =.02). IFN-gamma did not significantly alter airway fibroblast proliferation. CONCLUSION: IL-4, IL-13, and dexamethasone all significantly increased fibroblast proliferation in subjects with mild asthma.
BACKGROUND:IL-4 and IL-13 have been shown to be critical for expression of the asthma phenotype in a murine model and may modulate human fibroblast function. OBJECTIVE: We hypothesized that IL-4 and IL-13 would increase airway fibroblast proliferation and reduce the ability of dexamethasone to decrease this proliferation. METHODS: Six subjects with severe asthma, 5 subjects with mild asthma, and 5 healthy subjects underwent bronchoscopy with endobronchial biopsy. Biopsy specimens were placed in Dulbecco modified Eagle medium and cultured, and only fibro-blasts from the first and second passages were evaluated. Cells were incubated with IL-4 (50 ng/mL), IL-13 (10 ng/mL), and the combination for 48 hours in the presence and absence of dexamethasone, 10(-7) mol/L, and 10(-8) mol/L. Fibroblasts were also incubated with IFN-gamma at 50 ng/mL to assess the response of a T(H)1 cytokine on proliferation. RESULTS: Fibroblast proliferation, determined by (3)H-thymidine incorporation, was significantly increased by IL-4 in subjects with mild asthma as compared with IL-4 in subjects with severe asthma and healthy subjects (P =.003), IL-13 (P =.011), and the combination (P =.004). Dexamethasone also increased proliferation in the group with mild asthma as compared with the group with severe asthma and the healthy group (10(-7) mol/L, P =.02; 10(-8) mol/L, P =.02). IFN-gamma did not significantly alter airway fibroblast proliferation. CONCLUSION:IL-4, IL-13, and dexamethasone all significantly increased fibroblast proliferation in subjects with mild asthma.
Authors: Jennifer L Ingram; David Slade; Tony D Church; Dave Francisco; Karissa Heck; R Wesley Sigmon; Michael Ghio; Anays Murillo; Rafael Firszt; Njira L Lugogo; Loretta Que; Mary E Sunday; Monica Kraft Journal: Am J Respir Cell Mol Biol Date: 2016-01 Impact factor: 6.914
Authors: Jennifer L Ingram; Molly J Huggins; Tony D Church; Yuejuan Li; Dave C Francisco; Simone Degan; Rafael Firszt; Denise M Beaver; Njira L Lugogo; Ying Wang; Mary E Sunday; Paul W Noble; Monica Kraft Journal: Am J Respir Crit Care Med Date: 2011-03-25 Impact factor: 21.405
Authors: Rafael Firszt; Dave Francisco; Tony D Church; Joseph M Thomas; Jennifer L Ingram; Monica Kraft Journal: Eur Respir J Date: 2013-05-16 Impact factor: 16.671
Authors: Vibha N Lama; Hiroaki Harada; Linda N Badri; Andrew Flint; Cory M Hogaboam; Andrew McKenzie; Fernando J Martinez; Galen B Toews; Bethany B Moore; David J Pinsky Journal: Am J Pathol Date: 2006-07 Impact factor: 4.307
Authors: Hayley C Warsinske; Amanda K Wheaton; Kevin K Kim; Jennifer J Linderman; Bethany B Moore; Denise E Kirschner Journal: Front Pharmacol Date: 2016-06-23 Impact factor: 5.810